Clinical Trials on Moderate to Severe Idiopathic RLS With Daytime Symptoms in New Zealand
Total 23 results
-
PfizerCompleted
-
Egalet LtdCompletedModerate-to-severe Chronic Noncancer PainUnited States
-
AbbottCompletedModerate to Severe Chronic, Non-malignant PainUnited States
-
Egalet LtdCompletedModerate-to-severe Chronic Low Back PainUnited States
-
Novartis PharmaceuticalsCompletedModerate to Severe Palmoplantar PsoriasisBelgium, United States, Hungary, Russian Federation, Turkey, Australia, Israel, Netherlands, Portugal, Spain, United Kingdom, Norway, Slovakia, Canada, Finland
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisUnited States, Hungary, Italy, Russian Federation, Germany, Czechia, Canada
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisBelgium, Spain, Russian Federation, Germany, United States, Czechia, Peru, Poland, Estonia
-
Merz North America, Inc.Merz Pharmaceuticals GmbHCompletedModerate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)United States
-
Scilex Pharmaceuticals, Inc.Worldwide Clinical TrialsCompletedModerate to Severe Acute Lower Back PainUnited States
-
Tris Pharma, Inc.Forest LaboratoriesCompletedModerate to Severe Chronic Pain Due to Osteoarthritis of the KneeUnited States
-
Actavis Inc.Watson Laboratories, Inc.CompletedBACTERIAL VAGINOSIS | Signs and Symptoms to be Evaluated and Recorded Include | Vaginal Discharge Color, Odor, and Consistency | Vulvovaginal Itching and Irritation (Subjective) Absent, Mild, Moderate, or Severe | Vulvovaginal Inflammation (Objective) Absent, Mild, Moderate, or SevereUnited States, Dominican Republic, Puerto Rico
-
Hoffmann-La RochePfizerCompletedModerate to Severe Ulcerative ColitisUnited States, Australia, Thailand, Poland, Russian Federation, Japan, Colombia, Spain, Turkey, Romania, India, Slovakia, France, Hungary, South Africa, Belgium, Bulgaria, Germany, Italy, Mexico, Serbia, Ukraine, United Kingdom
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate to Severe Persistent AsthmaUnited States, China, Hungary, Korea, Republic of, Poland
-
UCB Biopharma S.P.R.L.CompletedModerate and Severe Active Rheumatoid Arthritis | Active Psoriatic Arthritis | Active Ankylosing Spondylitis | Moderately to Severely Active Crohn's DiseaseUnited States
-
UnicoCell Biomed CO. LTDProtech Pharmaservices Corporation (PPC)CompletedModerate to Severe Chronic Kidney DiseaseTaiwan
-
Regeneron PharmaceuticalsSanofiRecruitingModerate-to-Severe Atopic Dermatitis | Atopic EczemaUnited States
-
Novartis PharmaceuticalsGenentech, Inc.CompletedModerate to Severe Allergic AsthmaUnited States, Puerto Rico
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19United States, United Kingdom, Belgium, Spain, France, Germany, Philippines, Brazil, Colombia, South Africa
-
AstraZenecaAmgenCompletedModerate to Severe AsthmaUnited States
-
Mesoblast International SàrlNo longer availableModerate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19United States
-
Nuon Therapeutics, Inc.CompletedHyperuricemia | Moderate to Severe GoutUnited States
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the ProtocolUnited States, Mexico, South Africa, Brazil, Chile, Colombia, Peru, Argentina
-
Galderma R&DCompletedChronic Kidney Disease Associated Moderate to Severe PruritusSpain, United States, Hungary, Poland